A biotechnology platform for non-invasive diagnostics

Impacting global health by improving access to early diagnostic screening tests for infectious diseases

Our technology
Rapid diagnostic testing
We produce early diagnostic screening tools to make a sustainable impact on global health.

Non-invasive

Saliva based test

Anonymous

No trained medical staff required

Affordable

Zero expensive lab equipment

With your help we can change the world
Would you like to know more about our technology and its applications?
PARTNER WITH US
Innovative approach to detecting disease
We use a proprietary DNA based biotechnology to detect biomarkers in saliva without the need for trained medical staff or lab equipment.

Early detection of neglected tropical diseases (NTDs) is the best way to strengthen global health efforts in eradicating deadly diseases. We are partnering with leading health and research organizations to improve the quality of life of people suffering from NTDs. Our team of experienced scientists and business executives are driven by our purpose of making a sustainable impact on global health by innovating diagnostics.

Our team

Huram Konjen

CEO

Christian Code

CTO

Michelle Madelung

R&D Scientist

Bran Naras

Regulatory Specialist

Leif Larsen

Advisor

Inger Pedersen

Advisor

Ege Malling

Advisor

Shirin Khalili

Advisor
Contact us

A biotechnology platform for non-invasive diagnostics of infectious diseases. Shaping global health by improving access to early screening tests.

Contact us

Dianox ApS
Fruebjergvej 3
2100 Copenhagen
Denmark
contact@dianox.com